Sunday, January 16, 2011

Inverse Benefits Due to Drug Marketing Undermine Patient Safety and Public Health, Study Finds

ScienceDaily (2011-01-13) -- Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients -- a phenomenon described as the "inverse benefit law," according to new research.

No comments:

Post a Comment